[CLDX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
09-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 49.05%
YoY- -30.96%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 268 967 1,613 407 163 174 333 -13.51%
PBT -30,502 -29,361 -26,487 -26,784 -36,004 -23,050 -20,148 31.94%
Tax -3,459 -6,946 -2,796 -912 16,564 -1,486 -874 150.83%
NP -30,502 -22,415 -23,691 -26,784 -52,568 -21,564 -20,148 31.94%
Tax Rate - - - - - - - -
Total Cost 30,770 23,382 25,304 27,191 52,731 21,738 20,481 31.27%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -11,381.34 -2,317.99 -1,468.75 -6,580.84 -32,250.31 -12,393.10 -6,050.45 52.55%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.65 -0.47 -0.50 -0.57 -1.12 -0.46 -0.43 31.81%
EPS Diluted -0.65 -0.47 -0.50 -0.57 -1.12 -0.46 -0.43 31.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.